AnPac Bio-Medical Science - ADR Financials

$3.80

$-36.54 (-90.58%)

As on 21-Jul-2023 09:30EDT

Market cap

$27 Mln

Revenue (TTM)

$12 Mln

P/E Ratio

--

P/B Ratio

5.7

Div. Yield

0 %

Annual
Quarterly

Income Statement (CN¥ Mln)	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Operating Revenue	12.04	17.99	20.51	10.85	10.25	5.69
Cost of Revenue	3.71	5.73	7.63	6.05	5.67	3.95
Gross Profit	8.34	12.25	12.88	4.80	4.58	1.73
Operating Expenses	92.47	118.30	106.01	93.88	48.19	42.66
Operating Profit (EBIT)	-84.14	-106.05	-93.13	-89.08	-43.61	-40.92
Other Income	--	--	--	--	--	--
Profit before Tax	-105.73	-121.27	-80.65	-101.84	-42.50	-39.31
Provision for Tax	-2.13	-1.18	-0.09	-0.22	-0.20	0.01
Profit after Tax (Net Income)	-103.60	-120.09	-80.57	-101.62	-42.06	-39.08
Minority Interest	1.71	1.39	0.33	0.05	0.05	-0.06
Consolidated Profit	--	-118.70	-80.48	-101.06	-42.06	-39.08

Liabilities (CN¥ Mln)	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Shareholder's Funds	-13.68	-4.50	2.95	-15.97	-22.39	9.56
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	7.60	3.27	3.09	2.71	3.72	15.30
Current Liabilities	42.28	62.91	43.52	66.20	71.44	35.35
Total Liabilities	40.47	67.49	49.89	52.98	52.76	60.15

Assets (CN¥ Mln)	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Non-Current Assets	26.77	43.94	28.60	30.81	31.91	42.20
Current Assets	13.70	23.55	21.29	22.17	20.85	17.95
Total Assets	40.47	67.49	49.89	52.98	52.76	60.21
Total Debt*	12.31	33.76	8.23	38.57	25.96	12.50
Net Current Assets	-28.58	-39.36	-22.24	-44.03	-50.59	-17.40

Cashflow (CN¥ Mln)	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Cash From Operating Activities	-55.06	-71.71	-58.97	-48.60	-31.15	-21.64
Cash Flow from Investing Activities	--	-3.93	-2.48	-3.46	-2.68	-8.02
Cash from Financing Activities	49.47	83.42	60.92	46.11	36.27	39.81
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Adjusted EPS (CN¥)	--	--	--	--	--	--
Cash EPS (CN¥)	--	--	--	--	--	--
Adjusted Book Value (CN¥)	--	--	--	--	--	--
Dividend per Share (CN¥)	--	--	--	--	--	--
Cash Flow per Share (CN¥)	--	--	--	--	--	--
Free Cash Flow per Share (CN¥)	--	--	--	--	--	--

Profitability Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
ROCE (%)	-742.69	-593.90	-477.07	-776.83	-328.28	--
ROE (%)	1,140.01	15,485.11	1,237.08	529.75	655.44	--
ROA (%)	-191.92	-204.62	-156.64	-192.20	-74.51	--
EBIT Margin (%)	-698.59	-589.60	-454.07	-821.41	-403.29	-681.13
Net Margin (%)	-860.16	-667.67	-392.83	-937.03	-410.37	-687.23
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Revenue Growth (%)	-0.33	-0.12	0.89	0.06	0.80	--
EBIT Growth (%)	20.66	-13.87	-4.54	-115.50	-6.73	--
Net Profit Growth (%)	13.73	-49.06	20.72	-141.59	-7.64	--
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Solvency Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debt to Equity	-0.90	-7.50	2.79	-2.41	-1.16	1.31
Short term debt to equity ratio	-0.42	-7.50	2.79	-2.41	-1.16	1.31
Current Ratio	0.32	0.37	0.49	0.33	0.29	0.51
Quick Ratio	0.32	0.37	0.48	0.33	0.29	0.50
Interest Coverage	-225.57	-24.91	-81.48	-34.14	-44.69	-114.58

Operating Efficiency Ratios	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debtors to sales (%)	46.01	39.20	44.22	17.06	29.44	39.92
Asset Turnover	0.22	0.31	0.40	0.21	0.18	--
Receivable days	190.93	163.68	97.23	81.97	94.22	145.82
Inventory Days	34.48	25.55	14.96	11.33	9.72	22.17
Payable days	238.38	154.81	94.02	103.23	131.33	227.33
Cash Conversion Cycle	-12.97	34.42	18.18	-9.93	-27.39	-59.35